Pregabalin-13C3, 100 ug/mL,
|
P-106
|
100 µg/mL in Methanol
Sold under the trade name Lyrica®,
pregabalin is an anticonvulsant/antiepileptic drug used for treatment of seizures,
fibromyalgia, diabetic peripheral neuropathy, generalized anxiety
disorder, and chronic neuropathic pain. This internal standard is suitable for quantitation
of pregabalin levels in urine, serum, or plasma by GC/MS or LC/MS for urine
drug testing, clinical toxicology, or forensic analysis.
|
|
|
Coming soon, Cerilliant will introduce the following anticonvulsants/antiepileptics internal standards:
10,11-Dihydro-10-Hydroxycarbamazepine-13C6 (D-104)
Oxcarbazepine-13C6 (O-039)
Gabapentin-13C3 (G-018)